Recent advances in clinical trials for autoimmune diseases: Key devices and associated challenges

Autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and lupus affect millions worldwide. Ongoing clinical trials are making significant progress with new therapies and innovative devices. However, these advancements bring challenges in areas such as training, sourcing, and logistics – especially for global studies.

Article Written by: Erik Hoddenbach

Key developments in clinical trials for autoimmune diseases

  1. Biologics and precision medicine
    Biologic therapies, including monoclonal antibodies, are offering more targeted treatments by focusing on specific immune pathways. Precision medicine trials aim to customize treatments based on individual immune profiles, improving effectiveness for conditions like lupus and rheumatoid arthritis.
  2. Stem cell therapy
    Stem cell treatments, such as autologous hematopoietic stem cell transplantation (AHSCT), show promise in resetting the immune system. Trials for severe conditions like multiple sclerosis are advancing, with early results indicating potential remission in some cases.
  3. Gene editing (CRISPR)
    Early-stage trials are exploring CRISPR technology to edit immune cells and prevent autoimmune attacks. While still experimental, this approach could revolutionize treatments for Type 1 diabetes and other autoimmune diseases.

Essential devices in autoimmune disease clinical trials

  1. Imaging devices
    MRI and CT Scanners are essential for tracking disease progression, especially in neurological conditions like multiple sclerosis. Ultrasound machines monitor joint inflammation in rheumatoid arthritis, providing crucial trial data.
  2. Wearable monitoring devices
    Wearables, like continuous glucose monitors (CGMs) and smartwatches, track health metrics such as blood glucose, heart rate, and physical activity. These devices enable remote monitoring, which is increasingly important in decentralized clinical trials.
  3. Point-of-care diagnostic devices
    Portable diagnostic devices, like ELISA kits, allow real-time testing of autoimmune markers such as rheumatoid factor (RF). These help assess treatment efficacy on-site during trials.
  4. Drug delivery systems
    Devices like autoinjectors and infusion pumps are crucial for administering biologic treatments. Emerging technologies like microneedle patches offer the potential for easier, patient-friendly drug delivery.
Our equipment
A medical worker taking notes about clinical trial supply logistics while wearing sterile gloves with medical staff packing products in cardboard boxes in the background.

Essential devices in autoimmune disease clinical trials

While clinical advancements are promising, global trials face several logistical and operational challenges:

  1. Training and expertise
    Biologics, gene editing, and stem cell therapies require highly specialized knowledge. Ensuring that clinical staff worldwide are adequately trained on new treatments and devices can be difficult, especially in regions with fewer medical resources. Providing consistent education, hands-on training, and support for healthcare providers is critical for trial success.
  2. Sourcing and device availability
    Procuring advanced devices – such as MRI scanners, wearable sensors, or CRISPR gene-editing tools – can be challenging, especially in developing countries. Variations in device availability, regulatory requirements, and technology infrastructure across regions complicate global trials. Collaborating with local suppliers and ensuring device standardization is key to overcoming these hurdles.
  3. Logistics and distribution
    The complexity of shipping biologics, stem cell samples, or gene therapies across borders adds another layer of difficulty. These materials often require special handling (e.g., cold-chain logistics) to maintain their stability and efficacy. Moreover, wearable devices or diagnostic kits must be reliably distributed to remote or under-resourced areas for decentralized trials, increasing the complexity of managing supply chains and ensuring compliance with international regulations.
Our logistics services

Conclusion

Clinical trials for autoimmune diseases are making remarkable strides with biologics, stem cell therapies, and gene editing. However, challenges in training, sourcing, and logistics – especially for global studies – remain significant. Addressing these challenges through consistent training, efficient sourcing of devices, and streamlined logistics will be essential for the continued success of these trials and, ultimately, for improving patient outcomes worldwide.

Global sourcing with Clinichain

With extensive expertise in global equipment sourcing, Clinichain ensures essential devices are available at diverse trial sites. Our decentralized trial solutions expand access, enabling broader patient participation and more efficient data collection. Through tailored equipment rental and a vast network, we support seamless, cutting-edge trials across the globe.

Contact us